Clinical Indications for B12 Intravenous Treatment B12 IV treatment is for severe deficiencies, when oral supplements dont work
Nasal spray: 200400mcg per administration, 12 times daily
BPC 157 counteracts QTc prolongation induced by haloperidol, fluphenazine, clozapine, olanzapine, quetiapine, sulpiride, and metoclopramide in rats
Rosenfeld SV, Togo EF, Mikheev VS, Popovich IG, Khavinson VK, Anisimov VN
The infusion rate must be controlled to prevent bad reactions
Given the potential effects on angiogenesis and tissue growth, patients should be monitored for any signs of abnormal tissue proliferation or changes that could indicate malignant transformation